Browsing Pathways
Showing 64921 -
64930 of 605359 pathways
SMPDB ID | Pathway Name and Description | Pathway Class | Chemical Compounds | Proteins |
---|---|---|---|---|
SMP0129019View Pathway |
Zalutumumab Drug Metabolism |
|
||
SMP0130189View Pathway |
Zampilimab Drug Metabolism |
|
||
SMP0126040View Pathway |
Zanamivir Action PathwayZanamivir, also known as Relenza, is an inhibitor of the viral neuraminidase protein. This antiviral is used to treat and prevent influenza A and B infections. By interacting with the neuraminidase, Zabamivir renders the influenza virus unable to escape its host cell. Neuraminidases are essential for the cleaving of the terminal sialic acids on the glycosylated HA during the virus budding to facilitate its release. In consequence, the virus will not be able to infect other cells. This molecule is available as an intravenous solution or as a powder for inhalation.
|
Drug Action
|
||
SMP0143007View Pathway |
Zanamivir Drug Metabolism Action Pathway |
Drug Action
|
|
|
SMP0129802View Pathway |
Zanidatamab Drug Metabolism |
|
||
SMP0130196View Pathway |
Zansecimab Drug Metabolism |
|
||
SMP0129400View Pathway |
Zanthoxylum clava-herculis bark Drug Metabolism |
|
||
SMP0129374View Pathway |
Zanthoxylum clava-herculis whole Drug Metabolism |
|
||
SMP0130872View Pathway |
Zanubrutinib Drug MetabolismZanubrutinib is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Zanubrutinib passes through the liver and is then excreted from the body mainly through the kidney.
|
|
||
SMP0145237View Pathway |
Zanubrutinib Drug Metabolism Action Pathway |
Drug Action
|
|
|
Showing 64921 -
64930 of 65005 pathways